nivolumab,ipilimumab
bms
['hcrn,gu16,260', 'hcrn,gu,16,260', 'nivolumab', 'nivo', 'biomarker', 'renal,(-adrenal)']
biomarkers of response to first-line nivolumab therapy in patients with advanced #renalcellcarcinoma enrolled in the hcrn gu16-260 trial. presented by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology